BIA
RLAY icon

Bell Investment Advisors’s Relay Therapeutics RLAY Stock Holding History

Bell Investment Advisors’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-177
Closed -$1.49K – 1977
2023
Q3 		$1.49K Sell
177
-32
-15% -$344 ﹤0.01% 1415
2023
Q2 		$2.63K Hold
209
– – ﹤0.01% 1155
2023
Q1 		$3.44K Buy
209
+32
+18% +$574 ﹤0.01% 977
2022
Q4 		$2.64K Sell
177
-28
-14% -$536 ﹤0.01% 1137
2022
Q3 		$5K Buy
205
+177
+632% +$3.88K ﹤0.01% 707
2022
Q2 		$0 Buy
+28
New +$600 ﹤0.01% 1812
2021
Q4 		$1K Buy
35
+4
+13% +$126 ﹤0.01% 1578
2021
Q3 		$1K Buy
+31
New +$1.04K ﹤0.01% 1540

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Bell Investment Advisors's RLAY Position: Q4 2023 in Review

Bell Investment Advisors sold out of Relay Therapeutics (RLAY) in Q4 2023, closing a stake of 177 shares — an estimated $1.49K sold.

Bell Investment Advisors first reported a position in RLAY in Q3 2021 and held it in 8 quarters. The position peaked at $5K in Q3 2022. 177 funds tracked by Wall St. Rank hold RLAY as of Q4 2023.

  • Bell Investment Advisors reported no remaining Relay Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Bell Investment Advisors sold 177 Relay Therapeutics shares in Q4 2023, an estimated $1.49K.
  • Bell Investment Advisors first reported a position in Relay Therapeutics in Q3 2021 and held it in 8 quarters.
  • Bell Investment Advisors's Relay Therapeutics position peaked at $5K in Q3 2022.
  • 177 funds tracked by Wall St. Rank held Relay Therapeutics as of Q4 2023.

Based on Bell Investment Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.